MCID: PLS011
MIFTS: 56

Plasmacytoma

Categories: Cancer diseases, Neuronal diseases, Blood diseases, Rare diseases, Immune diseases

Aliases & Classifications for Plasmacytoma

MalaCards integrated aliases for Plasmacytoma:

Name: Plasmacytoma 12 56 52 42 14 69
Solitary Plasmacytoma 12 56
Solitary Osseous Plasmacytoma 69
Plasmacytoma - Category 69
Myeloma - Solitary 12
Myeloma, Solitary 12
Solitary Myeloma 12

Characteristics:

Orphanet epidemiological data:

56
plasmacytoma
Inheritance: Not applicable; Age of onset: Adult; Age of death: elderly;

Classifications:



External Ids:

Disease Ontology 12 DOID:3721
ICD10 33 C90.3 C90.30
MeSH 42 D010954
NCIt 47 C6932 C9349
Orphanet 56 ORPHA86855
MESH via Orphanet 43 D010954
UMLS via Orphanet 70 C0032131
ICD10 via Orphanet 34 C90.2 C90.3
UMLS 69 C0032131

Summaries for Plasmacytoma

MalaCards based summary : Plasmacytoma, also known as solitary plasmacytoma, is related to solitary plasmacytoma of chest wall and lymphoma, and has symptoms including bone pain An important gene associated with Plasmacytoma is IL6 (Interleukin 6), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Cyclophosphamide and Lenograstim have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and t cells, and related phenotypes are cellular and hematopoietic system

Wikipedia : 72 Plasmacytoma is a plasma cell dyscrasia in which a plasma cell tumour grows within soft tissue or within... more...

Related Diseases for Plasmacytoma

Diseases related to Plasmacytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 216)
id Related Disease Score Top Affiliating Genes
1 solitary plasmacytoma of chest wall 31.4 B2M CCND1 IGKC IL2 IL6
2 lymphoma 30.4 CD79A IL2 IL6
3 extramedullary plasmacytoma 12.2
4 anaplastic plasmacytoma 12.0
5 solitary osseous plasmacytoma 12.0
6 extramedullary soft tissue plasmacytoma 12.0
7 primary plasmacytoma of the bone 11.9
8 multiple myeloma 11.3
9 spirillary rat-bite fever 10.6 IL2 IL6
10 psychotic disorder 10.6 IL11 IL6
11 ovarian wilms' cancer 10.5 MYC PTPRC
12 46 xy gonadal dysgenesis 10.5 B2M CD79A
13 x-linked dominant intellectual disability-epilepsy syndrome 10.4 IL2 IL6
14 non-congenital cyst of kidney 10.4 B2M CD79A
15 generalized atherosclerosis 10.4 CD79A IL6
16 hemoglobinemia 10.4 CCND1 MYC
17 hemangioma of orbit 10.3 CD79A IL2
18 late yaws 10.3 B2M CD79A IL6
19 fallopian tube carcinoma 10.3 CD79A IL2
20 gallbladder cancer 10.3 CCND1 IL6 MYC
21 keloids 10.2 IL11 IL6 IL6R
22 cataract congenital autosomal dominant 10.2 IL6 IL6R
23 calcinosis 10.2 B2M CD79A IL6
24 theileriasis 10.2 B2M CD38
25 solitary bone cyst 10.2 B2M CD79A PTPRC
26 combined thymoma 10.2 CD38 CD79A
27 lymphocytic colitis 10.2 CD79A IL2 IL6
28 foodborne botulism 10.2 CD79A IL2 IL6
29 early congenital syphilis 10.2 CD79A IL2 IL6
30 heterotaxy, visceral, 4, autosomal 10.2 IL6 IL6R IL6ST
31 immune-complex glomerulonephritis 10.2 B2M CD79A
32 osteogenesis imperfecta, type x 10.2 IL6 IL6R IL6ST
33 legionellosis 10.2 CD79A IL2 IL6
34 acute interstitial pneumonia 10.2 CD79A IL2 IL6
35 post-surgical hypoinsulinemia 10.2 CCND1 IL2 MYC
36 chronic myelomonocytic leukemia 10.2 B2M CD79A IL6
37 opportunistic bacterial infectious disease 10.2 CD79A IL2 IL6
38 central nervous system origin vertigo 10.2 B2M CD79A IL2
39 mesenchymal cell neoplasm 10.2 CD79A IL2 IL6
40 lacrimal system cancer 10.1 CD79A IL2 IL6
41 thyroiditis 10.1
42 brown-vialetto-van laere syndrome 10.1 CCND1 IL2 MYC
43 immunodeficiency 11a 10.1 B2M CD38 IL2
44 pseudohypoparathyroidism 10.1 CD79A IL2 IL6
45 intracranial hemorrhage in brain cerebrovascular malformations 10.1 IL6 IL6ST MYC
46 adrenal gland disease 10.0 B2M CD38 CD79A
47 pneumonic plague 10.0 CCND1 CD38 MYC
48 leukemia 10.0
49 delta chain disease 10.0 CD38 CD79A PTPRC
50 cervicitis 9.9

Graphical network of the top 20 diseases related to Plasmacytoma:



Diseases related to Plasmacytoma

Symptoms & Phenotypes for Plasmacytoma

UMLS symptoms related to Plasmacytoma:


bone pain

MGI Mouse Phenotypes related to Plasmacytoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.2 IL6R IL6ST MYC PTPRC B2M CCND1
2 hematopoietic system MP:0005397 10.11 CCND1 CD38 CD79A EBF1 IL2 IL6
3 endocrine/exocrine gland MP:0005379 10.06 IL6R IL6ST MYC PTPRC B2M CCND1
4 homeostasis/metabolism MP:0005376 10.02 B2M CCND1 CD38 CD79A IL2 IL6
5 immune system MP:0005387 10 B2M CCND1 CD38 CD79A EBF1 IL2
6 digestive/alimentary MP:0005381 9.98 B2M CCND1 IL2 IL6 IL6ST MYC
7 liver/biliary system MP:0005370 9.81 B2M CD79A EBF1 IL2 IL6 IL6R
8 neoplasm MP:0002006 9.61 B2M CCND1 CD79A IL2 IL6 IL6R
9 nervous system MP:0003631 9.28 PTPRC B2M CCND1 CD79A EBF1 IL6

Drugs & Therapeutics for Plasmacytoma

Drugs for Plasmacytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 392)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
2
Lenograstim Approved Phase 4,Phase 3,Phase 2,Phase 1 135968-09-1
3 Thiotepa Approved Phase 4,Phase 2,Phase 1 52-24-4 5453
4 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1
5 Antilymphocyte Serum Phase 4,Phase 2,Phase 1
6 Antirheumatic Agents Phase 4,Phase 3,Phase 1,Phase 2
7 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
8
Bortezomib Approved, Investigational Phase 3,Phase 2,Phase 1 179324-69-7 387447 93860
9
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
10
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
11
Melphalan Approved Phase 3,Phase 2,Phase 1 148-82-3 4053 460612
12
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
13
Prednisone Approved, Vet_approved Phase 3,Phase 1,Phase 2 53-03-2 5865
14
Idarubicin Approved Phase 3 58957-92-9 42890
15
Lomustine Approved Phase 3 13010-47-4 3950
16
Methylprednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 83-43-2 6741
17
Prednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 50-24-8 5755
18
Carmustine Approved Phase 3,Phase 2,Phase 1 154-93-8 2578
19
Busulfan Approved, Investigational Phase 3,Phase 2,Phase 1 55-98-1 2478
20
Iron Approved Phase 3,Phase 2,Phase 1 7439-89-6 23925
21
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
22
Mycophenolate mofetil Approved, Investigational Phase 3,Phase 2,Phase 1 128794-94-5 5281078
23
Mycophenolic acid Approved Phase 3,Phase 2,Phase 1 24280-93-1 446541
24
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 22916-47-8 4189
25
Zoledronic acid Approved Phase 3,Phase 1,Phase 2 118072-93-8 68740
26
Pamidronate Approved Phase 3,Phase 2,Phase 1 40391-99-9 4674
27
Lenalidomide Approved Phase 3,Phase 2,Phase 1 191732-72-6 216326
28
Darbepoetin alfa Approved, Investigational Phase 3,Phase 2 11096-26-7, 209810-58-2
29
Ondansetron Approved Phase 3 99614-02-5 4595
30
Dextromethorphan Approved Phase 3 125-71-3 5360696 5362449
31
Guaifenesin Approved, Vet_approved Phase 3 93-14-1 3516
32
Morphine Approved, Investigational Phase 3 57-27-2 5288826
33
Dalteparin Approved Phase 3 9005-49-6
34
Heparin Approved, Investigational Phase 3 9005-49-6 772 46507594
35
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
36
deoxycholic acid Approved Phase 3 83-44-3 222528
37
Nystatin Approved, Vet_approved Phase 3 1400-61-9 11953884
38
Ephedrine Approved Phase 3 299-42-3 9294
39
Pseudoephedrine Approved Phase 3 90-82-4 7028
40
Amitriptyline Approved Phase 3 50-48-6 2160
41
Baclofen Approved Phase 3 1134-47-0 2284
42
Perphenazine Approved Phase 3 58-39-9 4748
43
Piperacillin Approved Phase 3 66258-76-2 43672
44
Tazobactam Approved Phase 3 89786-04-9 123630
45
Vancomycin Approved Phase 3 1404-90-6 441141 14969
46
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
47
Caspofungin Approved Phase 3,Phase 2 179463-17-3, 162808-62-0 468682 2826718
48 Ixazomib Approved Phase 3,Phase 2 1072833-77-2
49
Daratumumab Approved Phase 3,Phase 2 945721-28-8
50
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757

Interventional clinical trials:

(show top 50) (show all 381)

id Name Status NCT ID Phase Drugs
1 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4 cyclophosphamide;thiotepa
2 CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma Unknown status NCT02336386 Phase 3 CDD;CDD Plus Bortezomib
3 High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy Unknown status NCT00747877 Phase 3 cyclophosphamide;melphalan
4 Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma Unknown status NCT00028886 Phase 3 cyclophosphamide;dexamethasone;doxorubicin hydrochloride;melphalan;thalidomide;vincristine sulfate
5 Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma Unknown status NCT00014339 Phase 3 Wobe-Mugos E;melphalan;prednisone
6 Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma Unknown status NCT00003603 Phase 3 cyclophosphamide;dexamethasone;idarubicin;lomustine;melphalan;prednisolone
7 Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma Unknown status NCT00002653 Phase 3 carmustine;cyclophosphamide;doxorubicin hydrochloride;melphalan;prednisone
8 Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma Unknown status NCT00002599 Phase 3 carmustine;cyclophosphamide;doxorubicin hydrochloride;melphalan;methylprednisolone;prednisone;vincristine sulfate
9 Comparable Investigation of One Fraction Radiotherapy and Multifraction Radiotherapy in Patients With Multiple Myeloma. Unknown status NCT02024815 Phase 3
10 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Unknown status NCT00002989 Phase 3 busulfan;cyclophosphamide;idarubicin;melphalan
11 Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer Unknown status NCT00482716 Phase 3
12 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
13 Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma Completed NCT00432458 Phase 3 Thalidomide;zoledronic acid
14 Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple Myeloma Completed NCT00049673 Phase 3 prednisone;thalidomide
15 Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma Completed NCT00033332 Phase 3 dexamethasone;pamidronate disodium;thalidomide;zoledronic acid
16 Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma Completed NCT00017602 Phase 3 dexamethasone
17 Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Completed NCT00008229 Phase 3 melphalan
18 Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma Completed NCT00006232 Phase 3 dexamethasone;doxorubicin hydrochloride;idarubicin;vincristine sulfate
19 Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Completed NCT00004165 Phase 3 melphalan
20 Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma Completed NCT00002878 Phase 3 dexamethasone;doxorubicin hydrochloride;valspodar;vincristine sulfate
21 Combination Chemotherapy in Treating Patients With Multiple Myeloma Completed NCT00002678 Phase 3 dexamethasone;melphalan;prednisone
22 Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis Completed NCT00477971 Phase 3 dexamethasone;melphalan
23 S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma Completed NCT00064038 Phase 3 dexamethasone;lenalidomide
24 Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure Completed NCT00416897 Phase 3 chemotherapy;dexamethasone
25 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
26 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
27 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
28 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
29 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
30 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
31 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
32 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
33 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
34 Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy Completed NCT00003341 Phase 3
35 Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Completed NCT00075829 Phase 3 Thalidomide;Dexamethasone
36 Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer Completed NCT00002742 Phase 3 amphotericin B deoxycholate;nystatin
37 Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer Completed NCT00265837 Phase 3
38 Epoetin Alfa in Treating Anemia in Patients With Solid Tumors Completed NCT00058331 Phase 3
39 Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy Completed NCT00003600 Phase 3
40 Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder Completed NCT00755040 Phase 3 cyclosporine ophthalmic emulsion
41 Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer Completed NCT00516503 Phase 3 baclofen/amitriptyline/ketamine gel
42 Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Completed NCT00003805 Phase 3 piperacillin sodium;piperacillin-tazobactam;tazobactam sodium;vancomycin
43 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
44 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
45 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
46 Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma Recruiting NCT02544308 Phase 3 Lenalidomide;Dexamethasone
47 Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone Recruiting NCT02516423 Phase 3 ixazomib;lenalidomide;dexamethasone;zoledronic acid
48 Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma Active, not recruiting NCT02136134 Phase 3 Daratumumab;VELCADE (Bortezomib);Dexamethasone
49 Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00324324 Phase 3 moxifloxacin hydrochloride;Placebo
50 Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Unknown status NCT00742404 Phase 2 bortezomib;dexamethasone;pegylated liposomal doxorubicin hydrochloride

Search NIH Clinical Center for Plasmacytoma

Cochrane evidence based reviews: plasmacytoma

Genetic Tests for Plasmacytoma

Anatomical Context for Plasmacytoma

MalaCards organs/tissues related to Plasmacytoma:

39
Bone, Bone Marrow, T Cells, Kidney, Myeloid, Thyroid, Liver

Publications for Plasmacytoma

Articles related to Plasmacytoma:

(show top 50) (show all 1048)
id Title Authors Year
1
Primary extramedullary plasmacytoma mimicking oral lichen planus. ( 28944756 )
2017
2
Strategy for the treatment and follow-up of sinonasal solitary extramedullary plasmacytoma: a case series. ( 28793931 )
2017
3
T2 vertebrectomy with combined anterior and posterior arthrodesis for treatment of a solitary plasmacytoma. ( 28868185 )
2017
4
Complex interventional iliocaval recanalization due to plasmacytoma and cystic echinococcosis. ( 28613113 )
2017
5
Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment. ( 28507591 )
2017
6
Extramedullary plasmacytoma in the airway of an HIV-positive child. ( 28834349 )
2017
7
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue with plasma cell differentiation: Periodic acid-schiff reaction-positive Dutcher body is a diagnostic clue to distinguish it from plasmacytoma. ( 28233949 )
2017
8
18F-FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma. ( 28822997 )
2017
9
Extramedullary plasmacytoma of the lateral rectus muscle. ( 28267386 )
2017
10
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register. ( 28544116 )
2017
11
Bilateral plasmacytoma of the breast. ( 28805290 )
2017
12
Oral extramedullary plasmacytoma in a HIV positive patient. ( 27894848 )
2017
13
Extramedullary Plasmacytoma Arising From the Anterior Mediastinum. ( 28431708 )
2017
14
Plasmacytomas and Plasma-Cell Leukemia. ( 28296609 )
2017
15
Plasmacytoma of the clivus. ( 28761547 )
2017
16
A rare case of Epstein-Barr virus-related plasmacytoma involving maxillary sinus mucosa. ( 28878909 )
2017
17
Epibulbar Plasmacytoma Masquerading as Subconjunctival Hemorrhage in a Patient With Multiple Myeloma. ( 28060076 )
2017
18
Solitary Osteogenic Sternum Plasmacytoma on Bone Scintigraphy and FDG PET/CT. ( 28902727 )
2017
19
An extramedullary plasmacytoma in the kidney of a 14-year-old girl: Case report and review of the literature. ( 28178171 )
2017
20
Rare Presentation of Primary Extramedullary Plasmacytoma as Lip Lesion. ( 28409043 )
2017
21
Primary solitary plasmacytoma of the liver - successful treatment with fractionated stereotactic radiotherapy (CyberknifeAr): a case report. ( 28716071 )
2017
22
Cutaneous Plasmacytoma: Metastasis of Multiple Myeloma at the Fracture Site. ( 28761299 )
2017
23
Extramedullary plasmacytoma mimicking pancreatic cancer: A case report and literature review. ( 28663530 )
2017
24
An immunocompetent patient with a recurrence-free Epstein-Barr virus positive plasmacytoma possesses robust Epstein-Barr virus specific T-cell responses. ( 28705903 )
2017
25
Uterine Extramedullary Plasmacytoma as a Primary Manifestation of Multiple Myeloma. ( 28834996 )
2017
26
Relapsed Multiple Myeloma Presenting as Intracranial Plasmacytoma and Malignant Pericardial Effusion following Recent Allogeneic Stem Cell Transplantation. ( 28868016 )
2017
27
Desmin-positive anaplastic plasmacytoma involving the nasopharynx. ( 28168725 )
2017
28
Endoscopic ultrasound-guided fine needle aspiration and diagnosis of omental plasmacytoma. ( 28663527 )
2017
29
Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21(st) century. ( 28280077 )
2017
30
Solitary Plasmacytoma. ( 28894561 )
2017
31
Progression of cutaneous plasmacytoma to plasma cell leukemia in a dog. ( 28186653 )
2017
32
Bilateral extramedullary adrenal plasmacytoma: case report and review of the literature. ( 28758008 )
2017
33
An Extremely Rare Manifestation of Multiple Myeloma: An Immunoglobulin D Secreting Testicular Plasmacytoma. ( 28845377 )
2017
34
Composite Nasopharyngeal plasmacytoma with nodal paraimmunoblastic variant of small lymphocytic lymphoma: A case report. ( 28789404 )
2017
35
Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA. ( 28056880 )
2017
36
Clinical findings in 25 patients with sinonasal or nasopharyngeal extramedullary plasmacytoma in a four-decade single-centre series. ( 28537101 )
2017
37
Successful treatment of a primary gastric plasmacytoma mimicking intractable gastric ulcer by using high-dose dexamethasone therapy: a case report. ( 27036197 )
2016
38
Neuro-ophthalmic presentations of clival plasmacytoma. ( 27085275 )
2016
39
Solitary extraosseous plasmacytoma. ( 27648261 )
2016
40
Extramedullary Plasmacytoma Presenting With Acute Airway Compromise, Treated With Emergent Rigid Bronchoscopic Resection. ( 27058726 )
2016
41
Solitary Plasmacytoma of the Petrous Apex: A Case Report and Review of Literature. ( 27295445 )
2016
42
Bilateral synchronous plasmacytoma of the testis. ( 27034568 )
2016
43
Extraosseous plasmacytoma in the nasal cavity after rituximab therapy against pulmonary MALT lymphoma. ( 27435814 )
2016
44
Isolated nerve plasmacytoma in a patient previously in systemic myeloma remission. ( 28029682 )
2016
45
Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation. ( 27847663 )
2016
46
Orbital Plasmacytoma Mimicking an Orbital Abscess. ( 27046038 )
2016
47
Primary pulmonary plasmacytoma: a case report introduction. ( 27487779 )
2016
48
Solitary Bone Plasmacytoma of the Pelvis: A Rare Tumor. ( 27134717 )
2016
49
Endoscopic ultrasound-fine needle aspiration: A novel way to diagnose a solitary extramedullary plasmacytoma of the liver. ( 27080614 )
2016
50
Extramedullary Plasmacytoma of the Paranasal Sinuses: Combining Surgery with External Radiotherapy. ( 27066407 )
2016

Variations for Plasmacytoma

Expression for Plasmacytoma

Search GEO for disease gene expression data for Plasmacytoma.

Pathways for Plasmacytoma

Pathways related to Plasmacytoma according to GeneCards Suite gene sharing:

(show all 36)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.92 B2M CCND1 CD79A IL11 IL2 IL6
2
Show member pathways
13.17 B2M CCND1 IL11 IL2 IL6 IL6R
3 12.59 CCND1 IL2 IL6 IL6R MYC
4
Show member pathways
12.49 IL2 IL6 IL6R IL6ST MYC
5 12.33 CCND1 IL2 IL6 MYC
6 12.23 B2M CD38 CD79A IL2 IL6ST PTPRC
7
Show member pathways
12.16 CCND1 IL6R IL6ST MYC
8 12.1 CCND1 IL6 IL6R MYC
9
Show member pathways
12.03 CCND1 IL6 IL6R IL6ST
10 11.97 IL11 IL6 MYC
11 11.96 EBF1 IL6 IL6ST
12 11.89 CCND1 IL2 IL6 MYC
13 11.86 IL6 IL6R IL6ST
14
Show member pathways
11.86 IL2 IL6 IL6ST
15 11.85 CCND1 IL6 IL6R MYC
16
Show member pathways
11.82 IL6 IL6R IL6ST
17 11.8 CD79A IL6 PTPRC
18
Show member pathways
11.78 IL6 IL6R IL6ST
19 11.76 CD38 IL11 IL6 IL6R
20
Show member pathways
11.67 IL6 IL6R IL6ST MYC
21 11.61 CCND1 IL2 MYC
22
Show member pathways
11.59 CCND1 IL2 IL6
23 11.59 CD38 IL2 IL6 PTPRC
24 11.51 CD38 IL6R PTPRC
25 11.5 IL2 IL6 IL6R IL6ST PTPRC
26 11.5 CD38 CD79A IL11 IL2 IL6 PTPRC
27 11.48 CCND1 IL2 IL6
28 11.45 IL11 IL6 IL6R
29
Show member pathways
11.43 IL11 IL6 IL6R IL6ST
30
Show member pathways
11.41 CCND1 IL11 IL2 IL6 IL6R IL6ST
31
Show member pathways
11.38 IL6 IL6R IL6ST
32 11.33 CCND1 IL6 IL6R MYC
33 11.27 CCND1 IL6 MYC
34 11.23 IL6 IL6R IL6ST
35 11.18 IL11 IL2 IL6
36 10.94 CCND1 IL6ST

GO Terms for Plasmacytoma

Cellular components related to Plasmacytoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.86 B2M CNTN3 IGKC IL11 IL2 IL6
2 external side of plasma membrane GO:0009897 9.43 B2M CD79A IGKC IL6 IL6ST PTPRC
3 ciliary neurotrophic factor receptor complex GO:0070110 9.16 IL6R IL6ST
4 interleukin-6 receptor complex GO:0005896 8.8 IL6 IL6R IL6ST

Biological processes related to Plasmacytoma according to GeneCards Suite gene sharing:

(show all 19)
id Name GO ID Score Top Affiliating Genes
1 negative regulation of apoptotic process GO:0043066 9.91 CD38 IL2 IL6 IL6ST MYC
2 response to drug GO:0042493 9.83 B2M CCND1 CD38 IL6 MYC
3 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.71 IL11 IL6 IL6R
4 positive regulation of osteoblast differentiation GO:0045669 9.67 IL6 IL6R IL6ST
5 B cell receptor signaling pathway GO:0050853 9.67 CD38 CD79A IGKC PTPRC
6 positive regulation of B cell proliferation GO:0030890 9.63 CD38 IL2 PTPRC
7 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.62 IL2 IL6 IL6R IL6ST
8 positive regulation of chemokine production GO:0032722 9.58 IL6 IL6R
9 negative regulation of bone resorption GO:0045779 9.58 CD38 IL6
10 positive regulation of leukocyte chemotaxis GO:0002690 9.57 IL6 IL6R
11 positive regulation of acute inflammatory response GO:0002675 9.56 IL6 IL6ST
12 positive regulation of T cell proliferation GO:0042102 9.56 IL2 IL6 IL6ST PTPRC
13 positive regulation of immunoglobulin secretion GO:0051024 9.55 IL2 IL6
14 negative regulation of hormone secretion GO:0046888 9.52 IL11 IL6
15 ciliary neurotrophic factor-mediated signaling pathway GO:0070120 9.48 IL6R IL6ST
16 response to cytokine GO:0034097 9.46 CD38 IL6 IL6R IL6ST
17 hepatic immune response GO:0002384 9.4 IL6 IL6R
18 positive regulation of cell proliferation GO:0008284 9.17 CCND1 IL11 IL2 IL6 IL6R IL6ST
19 interleukin-6-mediated signaling pathway GO:0070102 9.13 IL6 IL6R IL6ST

Molecular functions related to Plasmacytoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 ciliary neurotrophic factor receptor activity GO:0004897 9.26 IL6R IL6ST
2 interleukin-6 receptor activity GO:0004915 9.16 IL6R IL6ST
3 interleukin-6 binding GO:0019981 8.96 IL6R IL6ST
4 interleukin-6 receptor binding GO:0005138 8.8 IL6 IL6R IL6ST

Sources for Plasmacytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....